What's breaking now, across thousands of outlets.
(RTTNews) - Actinium Pharmaceuticals, Inc. (ATNM), a clinical-stage biopharmaceutical company developing targeted radiotherapies for cancer, said Thursday it has appointed Matt David as chief financial officer.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Respiratory syncytial virus (RSV) causes substantial morbidity among older adults; however, RSV vaccination remains limited in Japan.
This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to its short form base shelf prospectus dated September 17…
Higher Education Commission (HEC) Chairman Prof. Dr. Niaz Ahmad Akhtar has pledged the commission’s support for screening students, faculty, and … Read More The post HEC to Support Free Hepatitis C…
The company stated that it foresees business of more than Rs 1,000 crore per year within five years of commissioning, with the new base helping it serve customers more efficiently, reduce import…
The pontiff’s tumor forces a rethink of his schedule, puts the November trip to Latin America in doubt, and raises questions about the future of his mandate
Nushrratt Bharuccha has been discharged from the hospital after successfully undergoing spine surgery following her unfortunate accident in Bali.
